Eversheds Sutherland
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Retained by leading pharmaceutical and life sciences companies for a comprehensive regulatory and transactional service, Eversheds Sutherland‘s life sciences practice is integrated into a global network. Recent work highlights include post-IPO regulatory support and the support on the development of novel treatments. Practice head Tobias Maier has a background in IP law and is a specialist in applying his experience to R&D projects for pharmaceutical and biotechnology firms, Anette Gärtner is a specialist in medical device patent litigation, and Nils Müller integrates experience in data protection and IT law to represent medical technology firms.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Tobias Maier, Steffen Morawietz, and Magdalena Kotyrba-Hagenmaier are very pleasant and friendly, easy-going personalities. They aee accessible, available and responsive, with a tremendous depth of knowledge and meaningful communication ability. They provide practical, solutions-oriented advice.'
Key clients
- Azurity Pharmaceuticals
- EuroEyes
Work highlights
Demonstrated responsibility for EU-wide assessments and project management in a regulatory transaction for Azurity Pharmaceuticals.